Patent details
88806 Product Name: NovoSeven® Eptacog alfa (activated)
Basic Information
- Publication number:
- 88806
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP863028551
- Legal Status:
- Expired
- Application number:
- 88806
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/96/006/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/02/1996
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- EU/1/96/006/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/02/1996
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 30/08/1996
- First Marketing Authorization date:
- 23/02/1996
- Grant date:
- 03/01/1997
- Activation date:
- 16/04/2006
- Publication date:
- 03/01/1997
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/02/2011
- SPC Extension Expiration:
- 23/02/2011
- Rejection date:
- Withdrawal date:
Owner
- From:
- 06/09/2006
- Name:
- NOVO NORDISK HEALTH CARE AG
- Address:
- ANDREASSTRASSE 15, 8050, ZÜRICH, Switzerland (CH)
History of Owners
- From:
- 30/08/1996
- To:
- 05/09/2006
- Name:
- ZYMOGENETICS, INC.
- Address:
- EASTLAKE AVENUE EAST 1201, 98102, SEATTLE, WA, United States (US)
Agent
- Name:
- WEYLAND J.J. PIERRE, DR
- From:
- 30/08/1996
- Address:
- PO Box 1775, 1017, Luxembourg, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|